Introduction: During the SARS-CoV-2 pandemic, the majority of healthcare resources of the affected Italian regions were allocated to COVID-19 patients. Due to lack of resources and high risk of death, most cancer patients have been shifted to non-surgical treatments. The following reports our experience of a Gynaecologic Oncology Unit's reallocation of resources in a COVID-19 free surgical oncologic hub in order to guarantee standard quality of surgical activities. Materials and methods: This is a prospective observational study performed in the Gynaecologic Oncology Unit, on the outcomes of the reallocation of surgical activities outside the University Hospital of Bologna, Italy, during the Italian lockdown period. Here, we described our COVID-19 free surgical oncologic pathway, in terms of lifestyle restrictions, COVID-19 screening measures, and patient clinical, surgical and follow up outcomes. Results: During the lockdown period (March 9th – May 4th, 2020), 83 patients were scheduled for oncological surgery, 51 patients underwent surgery. Compared to pre-COVID period, we performed the same activities: number of cases scheduled for surgery, type of surgery and surgical and oncological results. No cases of COVID-19 infection were recorded in operated patients and in medical staff. Patients were compliant and well accepted the lifestyle restrictions and reorganization of the care. CONCLUSIONSonclusions: Our experience showed that the prioritization of oncological surgical care and the allocation of resources during a pandemic in COVID-19 free surgical hubs is an appropriate choice to guarantee oncological protocols.

COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak / Perrone A.M.; Dondi G.; Giunchi S.; De Crescenzo E.; Boussedra S.; Tesei M.; D'Andrea R.; De Leo A.; Zamagni C.; Morganti A.G.; De Palma A.; De Iaco P.. - In: GYNECOLOGIC ONCOLOGY. - ISSN 0090-8258. - ELETTRONICO. - 161:1(2021), pp. 89-96. [10.1016/j.ygyno.2020.09.030]

COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak

Perrone A. M.;Dondi G.;Giunchi S.;De Crescenzo E.;Boussedra S.;Tesei M.;D'Andrea R.;De Leo A.;Zamagni C.;Morganti A. G.;De Iaco P.
2021

Abstract

Introduction: During the SARS-CoV-2 pandemic, the majority of healthcare resources of the affected Italian regions were allocated to COVID-19 patients. Due to lack of resources and high risk of death, most cancer patients have been shifted to non-surgical treatments. The following reports our experience of a Gynaecologic Oncology Unit's reallocation of resources in a COVID-19 free surgical oncologic hub in order to guarantee standard quality of surgical activities. Materials and methods: This is a prospective observational study performed in the Gynaecologic Oncology Unit, on the outcomes of the reallocation of surgical activities outside the University Hospital of Bologna, Italy, during the Italian lockdown period. Here, we described our COVID-19 free surgical oncologic pathway, in terms of lifestyle restrictions, COVID-19 screening measures, and patient clinical, surgical and follow up outcomes. Results: During the lockdown period (March 9th – May 4th, 2020), 83 patients were scheduled for oncological surgery, 51 patients underwent surgery. Compared to pre-COVID period, we performed the same activities: number of cases scheduled for surgery, type of surgery and surgical and oncological results. No cases of COVID-19 infection were recorded in operated patients and in medical staff. Patients were compliant and well accepted the lifestyle restrictions and reorganization of the care. CONCLUSIONSonclusions: Our experience showed that the prioritization of oncological surgical care and the allocation of resources during a pandemic in COVID-19 free surgical hubs is an appropriate choice to guarantee oncological protocols.
2021
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak / Perrone A.M.; Dondi G.; Giunchi S.; De Crescenzo E.; Boussedra S.; Tesei M.; D'Andrea R.; De Leo A.; Zamagni C.; Morganti A.G.; De Palma A.; De Iaco P.. - In: GYNECOLOGIC ONCOLOGY. - ISSN 0090-8258. - ELETTRONICO. - 161:1(2021), pp. 89-96. [10.1016/j.ygyno.2020.09.030]
Perrone A.M.; Dondi G.; Giunchi S.; De Crescenzo E.; Boussedra S.; Tesei M.; D'Andrea R.; De Leo A.; Zamagni C.; Morganti A.G.; De Palma A.; De Iaco P.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/808506
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact